Pfizer Stocks Edged Higher after FDA Full Approval
On Tuesday, August 24, Pfizer Inc. stocks climbed after receiving the FDA’s full approval. It is now the first vaccine firm to secure such validation. Pfizer closed Monday’s session with a 2.48% increase or a net gain of $1.21. This sent the stock price above $49.93 per share. On Tuesday’s session, it should open with …
Pfizer Stocks Edged Higher after FDA Full Approval Read More »